Wunderlich Securities »

Allogene Therapeutics shares owned by Wunderlich Securities

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Wunderlich Securities from 13F filings

Historical chart of Wunderlich Securities investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Wunderlich Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Wunderlich Securities

Quarter filed Position value Share count Share price at filing
2022-06-30 $2.7M 636 4237.42

More positions owned by Wunderlich Securities

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Proshares Tr Short S&p 500 Ne
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Johnson & Johnson (JNJ)
Rivernorth Opprtunities Fd I (RIV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Us Aer Def Etf (ITA)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Listed Fd Tr Horizon Kinetics (INFL)

View all positions for Wunderlich Securities

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics